Related Experiment Video
Updated: Jul 3, 2026

10:27
Determining Genetic Expression Profiles in C. elegans Using Microarray and Real-time PCR
Published on: July 30, 2011
Gene expression profiling of Nm23-H2 overexpressing CAL 27 cells using DNA microarray
M Herak Bosnar1, R Bago, P Konjevoda
1Rudjer Bosković Institute, Division of Molecular Medicine, Zagreb, Croatia. mherak@irb.hr
Neoplasma
|July 31, 2008
Summary
Nm23-H2, a nucleoside diphosphate kinase, influences oral cancer by affecting apoptosis, cell cycle, and signaling pathways. Further research is needed to confirm its role in oral squamous cell carcinoma progression.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Nucleoside diphosphate kinases (NDPKs), including Nm23-H1/NDPKA and Nm23-H2/NDPKB, are enzymes involved in nucleotide metabolism.
- Nm23 proteins are recognized for their metastasis suppressor activity, but their full range of functions and targets remain incompletely understood.
Purpose of the Study:
- To identify downstream targets of Nm23-H2 in oral squamous cell carcinoma (OSCC).
- To elucidate the biological pathways influenced by Nm23-H2 overexpression in OSCC cells.
Main Methods:
- Microarray analysis was performed on CAL 27 cells overexpressing Nm23-H2.
- Bioinformatic analysis was used to cluster identified genes and signaling pathways.
Main Results:
- Overexpression of Nm23-H2 led to significant alterations in genes and pathways related to apoptosis, cell cycle, and DNA damage.
- Modulations were observed in TGF-beta and WNT signaling pathways, as well as genes involved in differentiation, cell adhesion, and epithelial structure.
- Changes in metalloproteinases, vesicular transport, proteasome activity, and metabolic pathways were also identified.
Conclusions:
- Nm23-H2 plays a significant role in oral squamous cell carcinoma.
- The identified downstream targets suggest involvement in key cellular processes relevant to cancer progression.
- Further studies are warranted to validate these findings and explore therapeutic potential.

